4.3 Article

Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men

期刊

ANGIOLOGY
卷 67, 期 6, 页码 571-581

出版社

SAGE PUBLICATIONS INC
DOI: 10.1177/0003319715604762

关键词

epidemiology; sex differences; coronary angiography; major adverse cardiovascular events

资金

  1. Netherlands Heart Foundation [2013T084]
  2. Queen of Hearts: Improving diagnosis of CVD in women
  3. Royal Netherlands Academy of Arts and Sciences
  4. National University Singapore Startup grant
  5. Singapore National Medical Research Council Centre Grant
  6. ATTRaCT, grant BMRC [SPF 2014/003]
  7. UCL Hospitals NIHR Biomedical Research Centre
  8. Dutch Heart Foundation [2014T001]

向作者/读者索取更多资源

Background: Coronary artery disease affects both men and women. In this study, we examine sex-specific differences in occurrence of major adverse cardiovascular events (MACEs) after coronary angiography. Methods: We analyzed data from the coronary angiography cohort Utrecht Coronary Biobank (n = 1283 men, 480 women). Using Kaplan-Meier and multivariable Cox-regression, we tested for sex differences in MACE occurrence. Additionally, we compared mortality with an age- and sex-matched control group from the general Dutch population. Results: During a median follow-up of 2.1 years (interquartile range 1.6-2.8), MACEs occurred in 265 men and 103 women (20.7% vs 21.3%, P = .744). Women with myocardial infarction (MI) had significantly more MACE during follow-up than men (hazard ratio [HR] 1.66 for female sex, 95% confidence interval [CI] 1.10-2.50, P = .015), which was also the case for women who had multivessel disease (HR 1.41, 95% CI 1.03-1.94, P = .031). During follow-up, mortality in women presenting with MI was higher than mortality of women in the general population; men with MI did not show this disadvantage. Conclusion: MACEs occurred more often in women than in men who presented with MI or who had angiographic multivessel disease upon coronary angiography. Clinical trial registration: Clinicaltrials.gov identifier: NCT02304744. URL: https://clinicaltrials.gov/ct2/show/NCT02304744.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据